Clinical Trials
4 trialsNCT07486713 2026-06-05
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Rigel Pharmaceuticals
Phase 4 Recruiting
NCT05342883 2025-09-05
GESTALT
GT Medical Technologies, Inc.
Phase 4 Active not recruiting
NCT05900908 2025-04-10
PATHWAyS
GT Medical Technologies, Inc.
Phase 4 Withdrawn
NCT03513757 2020-02-21
Dexmedetomidine and Propofol for Pediatric MRI Sedation
Medical College of Wisconsin
Phase 4 Completed